17
Views
0
CrossRef citations to date
0
Altmetric
Research Article

In vitro cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug

ORCID Icon, ORCID Icon & ORCID Icon
Received 11 Nov 2023, Accepted 25 Apr 2024, Published online: 24 May 2024

References

  • Senwar K, Reddy T, Thummuri D, et al. Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene) indolin-2-ones as potential antitumor agents. Eur J Med Chem. 2016;118:34–46. doi:10.1016/j.ejmech.2016.04.025
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality world-wide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
  • Subramanian S, Boggu P, Yun J, et al. Identification of N-aryl sulfonyl-pyrimid ones as anticancer agents. Arch Pharmacal Res A Publ PSK. 2018;41:251–258. doi:10.1007/s12272-018-1003-9
  • Sung H, Ferlay J, Siegel R, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
  • Taiwan News. [ accessed on 2020 August 12]. www.taiwannews.com.tw/en/news/3948748
  • Mourad A, Rizzk Y, Zaki I, et al. Design, synthesis, cytotoxic screening and molecular docking studies of novel hybrid thio-semicarbazone derivatives as anticancer agents. J Mol Struct. 2021;1242:13072. doi:10.1016/j.molstruc.2021.130722
  • Ahmad A, Varshney H, Rauf A, et al. Synthesis and anticancer activity of long chain substituted 1,3,4-oxadiazol-2-thione, 1,2,4-triazol-3-thione and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine derivatives. Arab J Chem. 2017;46(S2):S3347–S3357. doi:10.1016/j.arabjc.2014.01.015
  • Anant A, Ali A, Ali A, et al. A Computational approach to discover potential quinazoline derivatives against CDK4/6 kinase. J Mol Struct. 2021;1245:131079. doi:10.1016/j.molstruc.2021.131079
  • Vitaku E, Smith D, Njardarson J. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen hetero-cycles among US. FDA Approv Pharm J Med Chem. 2014;57:10257–10274. doi:10.1021/jm501100b
  • Salman A, Abdel-Aziem A, Alkubbat M. Design, synthesis of some new thio-substituted imidazole and their biological activity. Am J Org Chem. 2015;5:57–72. doi:10.5923/j.ajoc.20150502.01
  • Nagalakshmi G. Synthesis and pharmacological evaluation of 2-(4-halosubstituted phenyl)-4,5-diphenyl-1H-imidazoles. J Chem. 2008;5:447–452. doi:10.1155/2008/921256
  • Gangadhar S, Ramesh D, Mahajan S. Synthesis, characterization and anticonvulsant activity of 3-substituted 2-thiohydantoin derivatives. Semant Sch IJRPC. 2013;3:793–796.
  • Ali I, Lone M, Aboul-Enein H. Imidazoles as potential anticancer agents. RSC Med Chem Commun. 2017;8:1731–1864. doi:10.1039/c7md00067g
  • Yoshino H, Sato H, Shiraishi T, et al. Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of a castration-resistant prostate cancer. Natl Libr Med. 2010;18:8150–8157. doi:10.1016/j.bmc.2010.10.023
  • Shih C, Wu J, Liu Y, et al. Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells. Biochem Pharm. 2004;67:67–75. doi:10.1016/j.bcp.2003.08.018
  • El-Sharief A, Moussa Z. Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidine-iminothiones and imidazolidine-iminodithiones with antitumor, antiviral, antibacterial and antifungal activities. Eur J Med Chem. 2009;44:4315–4334. doi:10.1016/j.ejmech.2009.07.019
  • Abadi A, Gary B, Tinsley H, et al. Synthesis, molecular modeling and biological evaluation of novel tadalafil analogs as phosphodiesterase and colon tumor cell growth inhibitors, new stereochemical perspective. Eur J Med Chem. 2010;45:1278–1286. doi:10.1016/j.ejmech.2009.10.046
  • Moussa Z, El-Sharief A, El-Sharief S. Synthesis and characterization of new types of halogenated and alkylated imidazoli-dine-iminothiones and a comparative study of their antitumor, antibacterial, and antifungal activities. Natl Libr Med. 2011;46:2280–2289. doi:10.1016/j.ejmech.2011.03.009
  • Aziz M, Khoobi M, Ramazani A, et al. A. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Natl Libr Med. 2013;59:15–22. doi:10.1016/j.ejmech.2012.10.044
  • El Hady H, El-Sayed R, Al-nathali H. Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties. Chem Cent J. 2018;51:3–12. doi:10.1186/s13065-018-0418-1
  • Hong-Ping Z, Ke X, Xiang-Hong H, et al. Organocatalytic diastereoselective [3+2] cyclization of MBH carbonates with dinucleophiles: synthesis of bicyclic imidazoline derivatives that inhibit MDM2-p53 interaction. Chem Comm. 2019;3:11374–11377. doi:10.1039/C9CC05916D
  • Vasir J, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat. 2005;4:363–374. doi:10.1177/153303460500400405
  • Han J, Talorete T, Yamada P, et al. Antiproliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 2009;59:45–53. doi:10.1007/s10616-009-9191-2
  • Wu C, Chen Y, Chen J, et al. Terpinen-4-ol induces apoptosis in human non-small cell lung cancer in vitro and in vivo. Evid-Based Complement Altern Med. 2012;2012:818261. doi:10.1155/2012/818261
  • Zaki I, Abdelhameid M, El-Deen I, et al. Design, synthesis and screening of 1,2,4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell lines. Eur J Med Chem. 2018;156:563–579. doi:10.1016/j.ejmech.2018.07.003
  • Khazaei S, Esa N, Ramachandran V, et al. In vitro antiproliferative and apoptosis inducing effect of allium atroviolaceum bulb extract on breast, cervical, and liver cancer cells. Front Pharmacol. 2017;8:1–16. doi:10.3389/fphar.2017.00005
  • Marcotte D, Zeng W, Hus J, et al. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem. 2013;21:4011–4019. doi:10.1016/j.bmc.2013.04.019
  • Thomsen R, Christensen M. A new technique for high accuracy molecular docking. J Med Chem. 2006;49:3315–3321. doi:10.1021/jm051197e
  • Fayed E, Sabour M, Harras A, et al. Design, synthesis, biological evaluation and molecular modeling of new coumarin derivatives as potent anticancer agents. Med Chem Res. 2019;28:1284–1297. doi:10.1007/s00044-019-02373-x.D
  • Kheirollahi A, Pordeli M, Safavi M, et al. Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines. Naunyn-Schmiedeberg's Arch Pharmacol. 2014;387:1199–1208. doi:10.1007/s00210-014-1038-5
  • Zhu J, Wang H, Chen F, et al. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radic. Biol. Med. 2016;99:544–556. doi:10.1016/j.freeradbiomed.2016.09.010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.